Yakira Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Yakira Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-620,019	Closed	-$791K	–	402
2023 Q3	$791K	Buy	+620,019	New	+$541K	0.21%	97

Yakira Capital Management's ZYNE Position: Q4 2023 in Review

Yakira Capital Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 620,019 shares — an estimated $791K sold.

Yakira Capital Management first reported a position in ZYNE in Q3 2023 and held it in 1 quarter. The position peaked at $791K in Q3 2023. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

Yakira Capital Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
Yakira Capital Management sold 620,019 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $791K.
Yakira Capital Management first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2023 and held it in 1 quarter.
Yakira Capital Management's Zynerba Pharmaceuticals, Inc position peaked at $791K in Q3 2023.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Yakira Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.